Sign in to continue:

Monday, April 13th, 2026

Author: Minichart

us corporate news

Fusemachines Inc. 2025 Annual Report: SEC 10-K Filing, Financial Overview, and Corporate Highlights

Minichart
March 28, 2026

FUSEMACHINES INC. 2025 Annual Report: Key Highlights for Inv...

Continue Reading 0
IPO

AI AutoVision®: Revolutionizing Chromosome Karyotyping with Intelligent Medical Imaging Solutions

Minichart
March 28, 2026

Hangzhou Diagens Biotechnology Co., Ltd. IPO: Comprehensive ...

Continue Reading 0
us corporate news

SKYX Platforms Corp. 2025 Annual Report (10-K/A): Financial Statements, Exhibits, and SEC Filings

Minichart
March 28, 2026

SKYX Platforms Corp. Files Amendment No. 1 to Annual Report ...

Continue Reading 0
IPO

Guangdong Huayan Robotics Co., Ltd. Global Offering: Hong Kong IPO Details, Application Process, and Key Dates (March 2026) 236

Minichart
March 28, 2026

Guangdong Huayan Robotics Co., Ltd. IPO Analysis – March 20,...

Continue Reading 0
us corporate news

Enveric Biosciences: Advancing Non-Hallucinogenic Psychedelic Drug Development for Mental Health Disorders

Minichart
March 28, 2026

Enveric Biosciences, Inc. 2025 Annual Report: Key Insights f...

Continue Reading 0
IPO

Epiworld International Co., Ltd. (Stock Code: 2726) Announces HKEX Global Offering Details and IPO Application Timeline for 2026

Minichart
March 28, 2026

Epiworld International Co., Ltd. IPO Analysis – March 20, 20...

Continue Reading 0
us corporate news

K&F Growth Capital II 2026 Annual Report: Business Strategy, Risk Factors, and SPAC Investment Insights

Minichart
March 28, 2026

KF Growth Acquisition Corp. II Annual Report: Key Investor T...

Continue Reading 0
us corporate news

Gesher Acquisition Corp. II 2025 Annual Report: Business Strategy, SPAC Criteria, and Risk Factors Explained

Minichart
March 28, 2026

Gesher I Acquisition Corp. 2025 Annual Report: Key Investor ...

Continue Reading 0
IPO

Financial Analysis Report

Minichart
March 28, 2026

Beijing Tong Ren Tang Healthcare Investment Co., Ltd. IPO An...

Continue Reading 0
us corporate news

Immix Biopharma, Inc. 2025 Annual Report Amendment: Financial Statements, Auditor Correction, and Company Overview

Minichart
March 28, 2026

Immix Biopharma, Inc. Files Amendment No. 1 to Annual Report...

Continue Reading 0